Increased bradykinin and “normal” angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats
- 1 July 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (1) , 211-221
- https://doi.org/10.1046/j.1523-1755.1999.00519.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)Kidney International, 1998
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.Journal of Clinical Investigation, 1997
- Renal Angiotensin-Converting Enzyme Localization in Diabetic Rats and the Effect of Low Protein DietNephron, 1997
- Comparison of B1and B2receptor activation on intracellular calcium, cell proliferation, and extracellular collagen secretion in mesangial cells from normal and diabetic ratsCanadian Journal of Physiology and Pharmacology, 1995
- Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 RatHypertension, 1995
- Nephrectomy, converting enzyme inhibition, and angiotensin peptides.Hypertension, 1993
- Bradykinin peptides in kidney, blood, and other tissues of the rat.Hypertension, 1993
- Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.Hypertension, 1991
- Design of rat renin inhibitory peptidesJournal of Medicinal Chemistry, 1988
- Glomerular Filtration Rate and Renal Plasma Flow in Short-term and Long-term Juvenile Diabetes MellitusScandinavian Journal of Clinical and Laboratory Investigation, 1971